Anticoccidial Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Anticoccidial Drugs market is segmented by Drug Type (Ionophore Anticoccidials and Chemical Derivative Anticoccidials), Animal, and Geography

Market Snapshot

anticoccidial market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 4 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Anticoccidial drugs market is being driven by factors such as the rising incidence of coccidiosis in food-producing animals and companion animals, coupled with the rising awareness regarding animal health across the globe.

Also, advancements in veterinary healthcare are one of the major factors fueling the growth of the market studied across the world. For instance, in April 2019, Creative Diagnostics announced the launch of a series of innovative anticoccidial drug analysis products and services for its global clients.

However, the use of alternative treatments, such as vaccines and herbal remedies, to treat Coccidiosis is likely to hamper the growth of anticoccidial drugs market across the world.

Scope of the Report

Coccidiosis is one of the most frequent and prevalent parasitic diseases among domesticated animals and its symptoms include weight loss, mild intermittent to severe diarrhoea, faeces containing mucus or blood, dehydration, and decreased breeding. Coccidiosis is caused by single-celled parasites (protozoa) called Eimeria, which undergo a simple life cycle in the gut. Any drug used to combat the progression of coccidiosis in birds or animals, both food-producing and non-food producing, is termed as an anticoccidial.

By Drug Type
Ionophore Anticoccidials
Chemical Derivative Anticoccidials
By Animal
Poultry
Swine
Fish
Cattle
Companion Animals
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Ionophore Anticoccidial segment dominates the Anticoccidial Drugs Market

  • A major breakthrough in the prevention of coccidiosis through feed medication occurred in 1972, with the launch of the first polyether ionophore anticoccidial, monensin. This type of anticoccidial agent has been commonly referred to as ionophores, a term derived from their general chemical structure. Ionophores are the fermentation products of Streptomyces and other fungi species.
  • Furthermore, these drugs are widely used for the prevention of coccidiosis, due to its broad-spectrum activity against the majority of pathogenic species of coccidian and lack of development of drug resistance. Each has a different mode of action and no significant resistance has been developed. These drugs are commonly added to the starter and grower feeds, but not to the finisher or withdrawal feeds.
  • Furthermore, when the same ionophore anticoccidial is added to the starter and grower feeds, it is known as a straight program. In 2017, the US Food and Drug Administration reported that 82% of all domestic sales and distribution of non-medically important antimicrobials were from ionophores, amounting to 4,394,850 kilo gram.
  • As a result of the aforementioned factors, the ionophore anticoccidial segment is expected to experience healthy growth during the forecast period.
anticoccodial.png

North America is the fastest growing region in the Anticoccidial Drugs Market

North America is the major market for anticoccidial drugs, globally. Currently, the North American anticoccidial drugs market is witnessing significant growth. This can be attributed to the availability of multiple anticoccidial drugs, both chemicals and polyether ionophores, as well as the prophylactic usage of anticoccidials in animal feed. Furthermore, factors, such as rising awareness regarding the prevention of coccidiosis, safe animal food supply, and high investment in R&D, mainly for developing novel products, are likely to propel the North American anticoccidial drugs market’s growth during the forecast period.

Anticoccidial Drugs Market - Growth Rate by Region - Image

Competitive Landscape

The anticoccidial market is competitive. Major market players are primarily focusing on continuous product development, while adopting growth strategies, such as mergers, acquisitions, and partnerships with other market players. Major players include Bayer Animal Healthcare, Boehringer Ingelheim, Ceva Animal Health Inc., Elanco Animal Health, Merck, Merial, Virbac, and Zoetis Animal Healthcare, among others.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increased Incidence of Coccidiosis, Globally

      2. 4.2.2 Advancements in Veterinary Healthcare

    3. 4.3 Market Restraints

      1. 4.3.1 Availability of Alternative Treatment Options in the Market

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Drug Type

      1. 5.1.1 Ionophore Anticoccidials

      2. 5.1.2 Chemical Derivative Anticoccidials

    2. 5.2 By Animal

      1. 5.2.1 Poultry

      2. 5.2.2 Swine

      3. 5.2.3 Fish

      4. 5.2.4 Cattle

      5. 5.2.5 Companion Animals

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East & Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Zoetis Animal Healthcare

      2. 6.1.2 Phibro Animal Health Corporation

      3. 6.1.3 Huvepharma

      4. 6.1.4 Elanco

      5. 6.1.5 Bayer AG

      6. 6.1.6 Ceva Animal Health Inc.

      7. 6.1.7 Impextraco NV

      8. 6.1.8 Virbac

      9. 6.1.9 Boehringer Ingelheim International GmbH

      10. 6.1.10 MSD Animal Health

      11. 6.1.11 Vetoquinol SA

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Anticoccidial Drugs Market market is studied from 2018 - 2026.

The Anticoccidial Drugs Market is growing at a CAGR of 4% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Impextraco NV, Vetoquinol SA, Phibro Animal Health Corporation, Huvepharma, Virbac are the major companies operating in Anticoccidial Drugs Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!